Substantial immune suppression required in gene therapy for muscular dystrophy?
To access this article, please choose from the options below
PII: S0960-8966(07)00718-3
doi:10.1016/j.nmd.2007.08.007
PII: S0960-8966(07)00718-3
doi:10.1016/j.nmd.2007.08.007